2 bargain shares to buy now for dividends

Christopher Ruane sees these two dividend-paying companies as shares to buy now for his portfolio at their current valuations.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Twenty pound notes in back pocket of jeans

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Looking for extra passive income, I have been scanning the stock market. Can I find dividend shares to buy now for my portfolio that look attractively priced? I think there are such shares and outline the case for a couple of contenders below.

The financial services provider Legal & General (LSE: LGEN) is the first of the two picks I would consider for my portfolio.

I think its business benefits from attractive long-term economics. A year, a decade, or even longer from now, millions of people will still want to insure their homes and vehicles, or invest some of their savings. To target that robust future customer demand, Legal & General has a significant competitive advantage due to its well-established brand. That should help it attract and retain customers, as well as potentially cross-sell them into other products from its range.

The business is a money-making machine and last year, profit after tax rose to £2bn. Given that the company’s revenues were £10.4bn, that means the post-tax profit margin was an impressive 19.7%.

High income potential

Such strong financial performance adds up to good news for shareholders. Currently the Legal & General dividend yield is 6.7%. On top of that, the company has set out plans to increase its dividend in coming years.

Dividends are never guaranteed, however, and there are risks here. An increase in storm damage could push up claim costs, hurting profits. The financial services market is also highly competitive, which could threaten profit margins.

In terms of valuation, the firm trades on a price-to-earnings ratio of eight. I reckon that is a bargain valuation for a company with the long-term growth rates, asset base, and proven business model of this famous firm.

Synthomer

The second share I would consider is aqueous polymers specialist Synthomer (LSE: SYNT). The company’s latest annual dividend means that it is currently offering an eye-watering yield of 9.8%. The 30p per share dividend was comfortably covered by basic earnings per share that came in at 75.2p.

With its strong position in an important part of many commercial production chains, Synthomer has been doing well thanks to strong demand. I am concerned, though, that cost inflation could damage profit margins over the next couple of years. Additionally, Nitrile latex demand is now subdued after previous stockpiling of items such as medical gloves. That could lead to revenues falling.

Shares to buy now for my portfolio

But I see such ups and downs of the demand cycle as an inevitable part of life for a basic materials producer like Synthomer. In the long term I expect demand for its products to remain substantial. That should help support profits.

The dividend jump last year reflected a pandemic-era demand surge. So I do not expect such a high payout in future. The company called the dividend raise an “exceptional increase reflecting the unique year of profitability”. But I still hope the company can still pay attractive dividends in future, even if at a lower level.

The price-to-earnings ratio is currently around seven. That valuation looks cheap to me, although if earnings fall next year the prospective P/E ratio would be higher. From a buy and hold perspective, I would be happy to add these shares to my portfolio.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Christopher Ruane has no position in any of the shares mentioned. The Motley Fool UK has recommended Synthomer. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »